Cargando…

Even after SARS-CoV-2 booster, there is increased COVID-19 breakthrough infection in patients with plasma cell disorders

Detalles Bibliográficos
Autores principales:	Fillmore, Nathanael R., La, Jennifer, Wu, Julie Tsu-Yu, Corrigan, June K., Branch-Elliman, Westyn, Monach, Paul, Brophy, Mary T., Do, Nhan V., Munshi, Nikhil C.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The American Society of Hematology 2023
Materias:	Research Letter
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10659994/ https://www.ncbi.nlm.nih.gov/pubmed/37647600 http://dx.doi.org/10.1182/bloodadvances.2023011063

Ejemplares similares

Increased COVID-19 Breakthrough Infection Risk after Sars-Cov-2 Vaccine Boosting in Patients with Plasma Cell Disorders: A Large Nationwide Veterans Affairs Study
por: Fillmore, Nathanael R, et al.
Publicado: (2022)

Increased COVID-19 breakthrough infection risk in patients with plasma cell disorders
por: La, Jennifer, et al.
Publicado: (2022)

Factors associated with the speed and scope of diffusion of COVID-19 therapeutics in a nationwide healthcare setting: a mixed-methods investigation
por: La, Jennifer, et al.
Publicado: (2022)

Recent common human coronavirus infection protects against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection: A Veterans Affairs cohort study
por: Fillmore, Nathanael R., et al.
Publicado: (2022)

Factors Associated With Severe COVID-19 Among Vaccinated Adults Treated in US Veterans Affairs Hospitals
por: Vo, Austin D., et al.
Publicado: (2022)

Inadequate Sars-Cov-2 Vaccine Effectiveness in Patients with Multiple Myeloma: A Large Nationwide Veterans Affairs Study
por: Fillmore, Nathanael R, et al.
Publicado: (2021)

Association of COVID-19 Vaccination With SARS-CoV-2 Infection in Patients With Cancer: A US Nationwide Veterans Affairs Study
por: Wu, Julie Tsu-Yu, et al.
Publicado: (2021)

Impact of prior SARS-CoV-2 infection on incidence of hospitalization and adverse events following mRNA SARS-CoV-2 vaccination: A nationwide, retrospective cohort study
por: Li, Lucy L., et al.
Publicado: (2022)

2656. Longitudinal Trends in Attributable Causes of Death Among US Veteran Patients with Documented SARS-CoV-2 Infection between January 2021 and March 2023
por: Trottier, Caitlin A, et al.
Publicado: (2023)

Reconsidering ‘minimal risk’ to expand the repertoire of trials with waiver of informed consent for research
por: Monach, Paul A, et al.
Publicado: (2021)

More data needed on efficacy and safety of monovalent vaccines against SARS-CoV-2 omicron variants
por: Monach, Paul A, et al.
Publicado: (2023)

Moving towards a precision approach for prevention of severe COVID-19
por: Branch-Elliman, Westyn, et al.
Publicado: (2023)

Bringing New Meaning to the Term “Adaptive Trial”: Challenges of Conducting Clinical Research During the Coronavirus Disease 2019 Pandemic and Implications for Implementation Science
por: Branch-Elliman, Westyn, et al.
Publicado: (2020)

Pragmatic, adaptive clinical trials: Is 2020 the dawning of a new age?
por: Branch-Elliman, Westyn, et al.
Publicado: (2020)

Prevalence and Outcome of COVID-19 Infection in Cancer Patients: A National Veterans Affairs Study
por: Fillmore, Nathanael R, et al.
Publicado: (2020)

Patient- reported reasons for non-participation in a COVID-19 therapeutics clinical trial: Findings from a multi-center investigation
por: Dassum, Samira Reyes, et al.
Publicado: (2023)

Automating surveillance for healthcare-associated infections: Rationale and current realities (Part I/III)
por: Shenoy, Erica S., et al.
Publicado: (2023)

Pandemic scientific data sharing recommendations: examining and re-imagining pre-print servers after the end of the world-wide emergency
por: Doron, Shira, et al.
Publicado: (2023)

1562MO Effectiveness of COVID-19 vaccination in cancer patients: A nationwide Veterans Affairs study
por: Wu, J.T-Y., et al.
Publicado: (2021)

Implementation of documented and written informed consent for clinical trials of communicable diseases: Lessons learned, barriers, solutions, future directions identified during the conduct of a COVID-19 clinical trial
por: Woods, Patricia, et al.
Publicado: (2021)

More intensive therapy has a better effect for frail parents with multiple myeloma
por: DuMontier, Clark, et al.
Publicado: (2023)

Economic Considerations in Infectious Diseases Emergency Response Preparedness: It’s All About the Point of View
por: Branch-Elliman, Westyn, et al.
Publicado: (2020)

1101. What Do Electrophysiologists Think about Peri-Procedural Antibiotics? A Qualitative Assessment of Factors Driving Use and Facilitators for Implementing Change
por: Branch-Elliman, Westyn, et al.
Publicado: (2019)

The next ‘pandemic playbook’ needs to prioritize the needs of children—and a clear roadmap for opening schools
por: Branch-Elliman, Westyn, et al.
Publicado: (2023)

1065. Patient-Reported Reasons for Non-Participation in Inpatient COVID-19 Clinical Research: Results from a Multi-Center VA Embedded Randomized Trial
por: Reyes Dassum, Samira, et al.
Publicado: (2022)

Risk factors of SARS-CoV-2 infection and complications from COVID-19 in lung cancer patients
por: Ganti, Apar Kishor, et al.
Publicado: (2023)

Using the Pillars of Infection Prevention to Build an Effective Program for Reducing the Transmission of Emerging and Reemerging Infections
por: Branch-Elliman, Westyn, et al.
Publicado: (2015)

Real-World Outcomes for Patients Treated With Immune Checkpoint Inhibitors in the Veterans Affairs System
por: La, Jennifer, et al.
Publicado: (2020)

2126. Comparative Effectiveness of Infection Prevention Interventions for Reducing Procedure-Related Cardiac Device Infections: Insights from the VA CART Program
por: Asundi, Archana, et al.
Publicado: (2018)

Embracing dynamic public health policy impacts in infectious diseases responses: leveraging implementation science to improve practice
por: Branch-Elliman, Westyn, et al.
Publicado: (2023)

The future of automated infection detection: Innovation to transform practice (Part III/III)
por: Branch-Elliman, Westyn, et al.
Publicado: (2023)

Leveraging electronic data to expand infection detection beyond traditional settings and definitions (Part II/III)
por: Branch-Elliman, Westyn, et al.
Publicado: (2023)

The Science Behind Safe School Re-opening: Leveraging the Pillars of Infection Control to Support Safe Elementary and Secondary Education During the COVID-19 Pandemic
por: Schechter-Perkins, Elissa M, et al.
Publicado: (2021)

Contemporary Analysis of Electronic Frailty Measurement in Older Adults with Multiple Myeloma Treated in the National US Veterans Affairs Healthcare System
por: DuMontier, Clark, et al.
Publicado: (2021)

1100. Facility Factors Are a Stronger Driver of Peri-Operative Vancomycin Use Than Patient Risk Factors
por: Branch-Elliman, Westyn, et al.
Publicado: (2019)

Prognostic value of the veterans affairs frailty index in older patients with non‐small cell lung cancer
por: Cheng, David, et al.
Publicado: (2022)

Sentiment analysis of medical record notes for lung cancer patients at the Department of Veterans Affairs
por: Elbers, Danne C., et al.
Publicado: (2023)

111. Increasing Duration of Surgical Prophylaxis Increases Antimicrobial-Associated Adverse Events but Does Not Decrease Surgical Site Infections: An Opportunity for Stewardship
por: Strymish, Judith M, et al.
Publicado: (2018)

858. Preoperative “Dirty” Urinalysis Leads to Antibiotic Use Without Benefit
por: Gallegos, Jaime, et al.
Publicado: (2018)

Does Adjunctive Tigecycline Improve Outcomes in Severe-Complicated, Nonoperative Clostridium difficile Infection?
por: LaSalvia, Mary T., et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_egq6adbf0dpr9j7oaeg7anj415